ClinConnect ClinConnect Logo
Search / Trial NCT06194994

Emotion Regulation as a Moderator of Two Different Treatments for Children With ODD

Launched by UNIVERSITY OF ICELAND · Jan 5, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Oppositional Defiant Disorder Emotion Regulation Child Psychopathology

ClinConnect Summary

This clinical trial is looking at how different treatments can help children with Oppositional Defiant Disorder (ODD) by focusing on their ability to manage emotions. The researchers want to find out if children do better with a specific type of treatment that matches their emotional challenges. They will divide participants into two groups: one group that has a lot of trouble with emotions and another that has less trouble. Each group will then be randomly assigned to either a parent training program that helps manage behavior or a treatment that teaches problem-solving and emotion regulation skills.

To be eligible for this study, children need to have a diagnosis of Oppositional Defiant Disorder and speak Icelandic with their parent or guardian. The trial is currently recruiting participants aged between 7 and 12 years old. Children who participate can expect to receive one of the two treatments, and their progress will be monitored to see which approach works best for them. It’s important to know that children with an IQ below 70 will not be included in the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with Oppositional Defiant Disorder
  • Icelandic speaking (child and parent/guardian)
  • Exclusion Criteria:
  • IQ below 70 (full scale score)

About University Of Iceland

The University of Iceland, a leading institution in research and higher education, serves as an innovative sponsor for clinical trials aimed at advancing medical knowledge and improving patient care. With a commitment to rigorous scientific inquiry and ethical standards, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research across various health disciplines. Collaborating with healthcare professionals and researchers, the University of Iceland fosters an environment that promotes groundbreaking studies, ultimately contributing to the global medical community and enhancing the health outcomes of diverse populations.

Locations

Reykjavik, , Iceland

Patients applied

0 patients applied

Trial Officials

Urdur Njardvik, PhD

Principal Investigator

Department of Psychology, University of Iceland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported